Skip to main content
Log in

Plasma lipids and lipoproteins in juvenile chronic arthritis

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Altered levels of high density lipoprotein (HDL), low density lipoprotein (LDL), and very-low density lipoprotein (VLDL), as well as apolipoproteins have been previously described in rheumatoid arthritis patients. We have attempted to evaluate the serum triglyceride, total cholesterol, cholesterol in DHL, LDL, apolipoprotein A1 (apo-A1) and apolipoprotein B (apo-B) levels in juvenile chronic arthritis (JCA) and to correlate them with CRP and ESR in the active and non-active stages of JCA. A total of 37 children who fulfilled ARA criteria for the diagnosis of JCA were studied. There were 18 girls and 19 boys. Age range was 2.5–16 years with a mean of 9.5. The mean duration of disease was 1.8 years. Nineteen patients were accepted to have active disease. Eighteen age and sex matched healty children served as controls. Apo-A1 was significantly lower in the active JCA group when compared to inactive patients and healthy controls (both p<0.05). There were significant inverse correlations between apo-A1 and both ESR and CRP levels in these patients (r=0.67, p<0.05 and r=−0.61, p<0.–05, respectively). Although mean LDL levels were numerically lower in the JCA patients (67.2 mg/dl in the active and 68.6 mg/dl in the inactive patients) the difference with healthy controls (91.7 mg/dl) was not statistically significant. There was no significant differences in regard to triglyceride, total cholesterol, cholesterol in HDL, and apo-B levels between neither of the groups. We conclude that JCA patients have a dyslipoproteinaemic state with already altered metabolism of lipids at different stages of the chronic inflammation from active to inactive disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ilowite, NT., Samuel, P., Ginzler, E., et al. Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis Rheum. 1988; 31 (7): 859–863.

    PubMed  Google Scholar 

  2. Svenson, KLG., Lithel, H., Hällgren, R. et al. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Inter Med 1987; 147: 1912–1916.

    Google Scholar 

  3. Svenson, KLG., Lithell, H., Hällgren, R. et al. Serum lipoprotein inactive rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. Arch Inter Med 1987; 147: 1917–20.

    Google Scholar 

  4. Lorber, M., Aviram, M., Linn, S. et al. Hypocholesterolemia and abnormal high-density lipoprotein in rheumatoid arthritis. Br J Rheumatol 1985; 24: 250–255.

    PubMed  Google Scholar 

  5. Lazarevic MB, Vitic J, Mladenovra V, et al. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum 1992; 22: 172–180.

    PubMed  Google Scholar 

  6. Ilowite, NT., Samuel, P., Beseler, L. et al. Dyslipoproteinemia in juvenile rheumatoid arthritis. J Pediatr 1989; 114: 823–826.

    PubMed  Google Scholar 

  7. Cassidy, JT., Petty, RE. Juvenile rheumatoid arthritis. In: Textbook of Pediatric Rheumatology, New York (2nd ed.): Churchill Livingstone, 1990: 113–220.

    Google Scholar 

  8. Dahlquist, SR., Jonsson, SW., Dahlen, G. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis. 1991; 50: 366–368.

    PubMed  Google Scholar 

  9. Rowe, IF., Souter, N., Troyner, TM. et al. Circulating human C-reactive protein binds very low density lipoproteins. Clin Exp Immunol 1984; 58: 237–244.

    PubMed  Google Scholar 

  10. Cabana, VB., Gewurz, H., Siegel, JN. Inflammation-induced changes in rabbit CRP and plasma lipoproteins. J Immunol 1983: 130: 1736–42.

    PubMed  Google Scholar 

  11. Cabana, VG., Siegel, JN., Sobesin, SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apalipoproteins. J Lipid Res 1989; 30: 39.

    PubMed  Google Scholar 

  12. Beutler, BA., Cerami, A. Recombinant IL1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 1985: 135(6) 3969–3971.

    PubMed  Google Scholar 

  13. Strandberg, O. Anaemia in rheumatoid arthritis Acta Med Scand 1966; 179 (suppl): 53–60.

    Google Scholar 

  14. Lazarevic, MB, Vitic, J., Miladenovic, MV. et al. Antilipoprotein antibodies in rheumatoid arthritis. Sem Arth Rheum 1993; 22: 385–97.

    Google Scholar 

  15. Miller, GJ., Miller, NE. Plasma high density lipoprotein concentration and the development of ischaemic heart disease. Lancet 1975; i: 16–18.

    Google Scholar 

  16. Dahlen, GH. Lp(a) Lipoprotein in cardiovascular disease. Atherosclerosis. 1994; 108: 111–126.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bakkaloglu, A., Kirel, B., Ozen, S. et al. Plasma lipids and lipoproteins in juvenile chronic arthritis. Clin Rheumatol 15, 341–345 (1996). https://doi.org/10.1007/BF02230355

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02230355

Key words

Navigation